Cabot (NYSE:CBT) Posts Earnings Results, Beats Expectations By $0.14 EPS

Cabot (NYSE:CBT) issued its quarterly earnings results on Tuesday. The specialty chemicals company reported $1.61 earnings per share for the quarter, topping analysts’ consensus estimates of $1.47 by $0.14, Zacks reports. Cabot had a net margin of 8.62% and a return on equity of 22.82%. Cabot updated its FY 2026 guidance to 6.000-6.50 EPS.

Cabot Price Performance

CBT stock traded up $3.12 during midday trading on Tuesday, reaching $78.97. 500,438 shares of the stock were exchanged, compared to its average volume of 433,033. Cabot has a 52 week low of $58.33 and a 52 week high of $83.71. The company has a fifty day moving average price of $73.60 and a 200 day moving average price of $70.18. The company has a debt-to-equity ratio of 0.49, a current ratio of 1.67 and a quick ratio of 1.09. The stock has a market capitalization of $4.12 billion, a PE ratio of 13.83, a P/E/G ratio of 10.20 and a beta of 0.78.

Cabot Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, June 12th. Investors of record on Friday, May 29th will be given a dividend of $0.4725 per share. The ex-dividend date is Friday, May 29th. This represents a $1.89 dividend on an annualized basis and a yield of 2.4%. This is an increase from Cabot’s previous quarterly dividend of $0.45. Cabot’s dividend payout ratio is presently 31.52%.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on the company. Zacks Research raised Cabot from a “strong sell” rating to a “hold” rating in a report on Tuesday, January 27th. Mizuho set a $75.00 price objective on Cabot and gave the stock a “neutral” rating in a research report on Wednesday, February 4th. Jefferies Financial Group reaffirmed a “buy” rating and issued a $85.00 price objective on shares of Cabot in a research note on Wednesday, February 4th. Finally, UBS Group lifted their target price on Cabot from $74.00 to $81.00 and gave the company a “neutral” rating in a research report on Thursday, February 5th. One investment analyst has rated the stock with a Buy rating, four have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $73.75.

Institutional Trading of Cabot

Several hedge funds and other institutional investors have recently made changes to their positions in CBT. NewEdge Advisors LLC raised its holdings in Cabot by 2,559.5% in the 1st quarter. NewEdge Advisors LLC now owns 984 shares of the specialty chemicals company’s stock valued at $82,000 after buying an additional 947 shares during the last quarter. Goldman Sachs Group Inc. grew its holdings in Cabot by 32.5% during the 1st quarter. Goldman Sachs Group Inc. now owns 442,646 shares of the specialty chemicals company’s stock worth $36,802,000 after acquiring an additional 108,645 shares during the last quarter. Empowered Funds LLC increased its position in Cabot by 102.6% in the 1st quarter. Empowered Funds LLC now owns 28,162 shares of the specialty chemicals company’s stock valued at $2,341,000 after acquiring an additional 14,260 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its stake in shares of Cabot by 3.4% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 122,022 shares of the specialty chemicals company’s stock valued at $10,145,000 after acquiring an additional 4,048 shares during the last quarter. Finally, Geneos Wealth Management Inc. lifted its holdings in shares of Cabot by 409.0% during the first quarter. Geneos Wealth Management Inc. now owns 453 shares of the specialty chemicals company’s stock worth $38,000 after purchasing an additional 364 shares during the period. 93.18% of the stock is currently owned by institutional investors.

Cabot Company Profile

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.